Back to School: How biopharma can reboot drug development. Access exclusive analysis here

BioTime completes private placement of common stock and warrants

BioTime Inc. (NYSE-M:BTX), Alameda, Calif.
Business: Gene/Cell therapy,

Read the full 81 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE